Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 20, 2015 10:00 ET | Source: Qu Biologics;BC Cancer Agency

Qu Biologics Launches Phase 2a Clinical Trial for Non-small Cell Lung Cancer (NSCLC)

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 20, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
December 04, 2014 10:00 ET | Source: Qu Biologics

Qu Biologics Welcomes Gastroenterologist Dr. Remo Panaccione to IBD Advisory Team

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 4, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
October 29, 2014 09:30 ET | Source: Qu Biologics

Qu Biologics' Crohn's Disease Clinical Trial Completes Independent Safety Review

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 29, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
September 17, 2014 10:05 ET | Source: Qu Biologics

Qu Biologics Closes Oversubscribed Private Funding Round of CDN$5.1 Million

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 17, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
June 17, 2014 10:30 ET | Source: Qu Biologics

Qu Biologics Appoints Dr. Bob Cory as Vice President, Business Development

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 17, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
June 04, 2014 10:00 ET | Source: Qu Biologics

Qu Biologics Granted Broad New Zealand Patent Involving Immunotherapies Derived from Viruses for Treating a Range of Cancers

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 4, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
May 20, 2014 13:07 ET | Source: Qu Biologics

Qu Biologics Granted U.S. Patent for Use of E. coli to Treat Colon Cancer

VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 20, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
April 28, 2014 14:45 ET | Source: Qu Biologics

Qu Biologics to Present Crohn's Disease Compassionate Use Results at Digestive Diseases Week Conference

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 28, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
February 20, 2014 20:49 ET | Source: Qu Biologics

Qu Biologics Opens Crohn's Disease Clinical Trial to U.S. Participants

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 20, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
February 18, 2014 09:00 ET | Source: Qu Biologics

Qu Biologics Opens Crohn's Disease Clinical Trial to U.S. Participants

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 18, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right